@misc{moraya_ali_samadder_liang_morrison_werbowetski-ogilvie_ogunsina_schweizer_arthur_nachtigal_2017, 
  title={Additional file 8: Figure S7. of Novel glycolipid agents for killing cisplatin-resistant human epithelial ovarian cancer cells}, 
  DOI={10.6084/m9.figshare.c.3778562_d8.v1}, 
  abstractNote={Viability of primary EOC183A cells treated with GAELs alone or pretreated with the pan-caspase inhibitor QVD. No significant difference in cell viability was observed in the presence of QVD, with the exception of the cisplatin positive control. * significantly different from vehicle control; + significantly different from cisplatin alone; pâ}, 
  publisher={Figshare}, 
  author={Moraya, Amani and Ali, Jennifer and Samadder and Liang, Lisa and Morrison, Ludivine and Werbowetski-Ogilvie, Tamra and Ogunsina and Schweizer, Frank and Arthur, Gilbert and Nachtigal, Mark}, 
  year={2017}, 
  month={May}
  }